This announcement is a separate document:
康諾亞-B：內幕消息公告 司普奇拜單抗獲得國家藥品監督管理局批准上市用於治療成人中重度特應性皮炎
KEYMED BIO-B: INSIDE INFORMATION ANNOUNCEMENTSTAPOKIBART WAS GRANTED MARKETING APPROVAL FROMNATIONAL MEDICAL PRODUCTS ADMINISTRATION FOR THETREATMENT OF MODERATE-TO-SEVEREATOPIC DERMATITIS IN ADULTS
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated